Read + Share
Brautigam K, Schmidt T, Baur M, Tauber N, et al. Prevalence of PD-L1 in Cervical Cancer Patients and the Potential for Combining
an Immune Checkpoint Inhibitor With Lenvatinib. Anticancer Res 2024;44:503-510.
PMID: 38307554
|
 |
|
Brautigam K, Schmidt T, Baur M, Tauber N, et al. Prevalence of PD-L1 in Cervical Cancer Patients and the Potential for Combining
an Immune Checkpoint Inhibitor With Lenvatinib. Anticancer Res 2024;44:503-510.
PMID: 38307554
|
|
|
|